Abstract

Surrogate endpoints have been used to assess the efficacy of a treatment and can potentially reduce the duration and/or number of required patients for clinical trials. Using information theory, Alonso et al. (2007) proposed a unified framework based on Shannon entropy, a new definition of surrogacy that departed from the hypothesis testing framework. In this paper, a new family of surrogacy measures under Havrda and Charvat (H-C) entropy is derived which contains Alonso’s definition as a particular case. Furthermore, we extend our approach to a new model based on the information-theoretic measure of association for a longitudinally collected continuous surrogate endpoint for a binary clinical endpoint of a clinical trial using H-C entropy. The new model is illustrated through the analysis of data from a completed clinical trial. It demonstrates advantages of H-C entropy-based surrogacy measures in the evaluation of scheduling longitudinal biomarker visits for a phase 2 randomized controlled clinical trial for treatment of multiple sclerosis.

Highlights

  • Surrogate endpoints which can be observed earlier, easier, possibly repeated, or are cost-saving, have been used to replace clinical endpoints in clinical trials

  • Total tumor response rate and progression–free survival have been used in phase II and phase III cancer clinical trials as surrogate endpoints for overall survival, which often requires a longer trial duration to achieve adequate statistical power

  • A binary response status, such as the total response based on the RECIST criterion [3], or a continuous response in change of tumor sizes [4] are common primary endpoints

Read more

Summary

Introduction

Surrogate endpoints which can be observed earlier, easier, possibly repeated, or are cost-saving, have been used to replace clinical endpoints in clinical trials. We present two new results on the topic of surrogate endpoints based on information-theoretic measure of association (ITMA). To extend H-C entropy to measure the endpoint surrogacy for trials, we define the ITMA under H-C entropy power as the following:. When two binary endpoints have more chance to be concordant, the mutual information will be an increasing function of correlation coefficient of ρ as shown in Proposition 3 Result 3.2.

Model for Longitudinal Continuous Surrogate Biomarkers in Phase II Trials
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call